Department of Biochemistry, University of Missouri , Columbia, Missouri 65211, United States.
Biochemistry. 2013 May 28;52(21):3638-50. doi: 10.1021/bi301662w. Epub 2013 May 16.
Formation of protein aggregates in the aging eye lens has been shown to correlate with progressive accumulation of specific low-molecular weight (LMW) peptides derived from crystallins. Prominent among the LMW fragments is αA66-80, a peptide derived from αA-crystallin and present at higher concentrations in the water-insoluble nuclear fractions of the aging lens. The αA66-80 peptide has amyloid-like properties and preferentially insolubilizes α-crystallin from soluble lens fractions. However, the specific interactions and mechanisms by which the peptide induces α-crystallin aggregation have not been delineated. To gain insight into the mechanisms of peptide-induced aggregation, we investigated the interactions of the peptide with α-crystallin by various biochemical approaches. The peptide weakens α-crystallin chaperone ability and drastically promotes α-crystallin aggregation via the formation of insoluble peptide-protein complexes through transient intermediates. 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic acid studies suggest that the peptide induces changes in the hydrophobicity of α-crystallin that could trigger the formation and growth of aggregates. The peptide-α-crystallin aggregates were found to be resistant to dissociation by high ionic strengths, whereas guanidinium hydrochloride and urea were effective dissociating agents. We conclude that the αA66-80 peptide forms a hydrophobically driven, stable complex with α-crystallin and reduces its solubility. Using isotope-labeled chemical cross-linking and mass spectrometry, we show that the peptide binds to multiple sites, including the chaperone site, the C-terminal extension, and subunit interaction sites in αB-crystallin, which may explain the antichaperone property of the peptide and the consequential age-related accumulation of aggregated proteins. Thus, the α-crystallin-derived peptide could play a role in the pathogenesis of cataract formation in the aging lens.
在衰老的眼睛晶状体中,蛋白质聚集体的形成已被证明与特定低分子量 (LMW) 肽的逐渐积累有关,这些肽源自晶状体蛋白。在 LMW 片段中,αA66-80 肽是一种源自 αA-晶体蛋白的肽,在衰老晶状体的不溶性核部分中浓度更高。该肽具有淀粉样特性,并且优先使可溶性晶状体部分的α-晶体蛋白不溶。然而,肽诱导α-晶体蛋白聚集的具体相互作用和机制尚未确定。为了深入了解肽诱导聚集的机制,我们通过各种生化方法研究了肽与α-晶体蛋白的相互作用。该肽通过形成不溶性肽-蛋白复合物通过瞬态中间物削弱α-晶体蛋白的伴侣能力,并极大地促进α-晶体蛋白聚集。4,4'-二苯胺基-1,1'-联萘-5,5'-二磺酸研究表明,该肽诱导α-晶体蛋白疏水性的变化,可能触发聚集的形成和生长。发现该肽-α-晶体蛋白聚集体不易通过高离子强度解离,而盐酸胍和尿素是有效的解离剂。我们得出结论,αA66-80 肽与α-晶体蛋白形成一个疏水驱动的稳定复合物,并降低其溶解度。使用同位素标记的化学交联和质谱,我们表明该肽结合到多个位点,包括伴侣位点、C 末端延伸和αB-晶体蛋白的亚基相互作用位点,这可能解释了该肽的抗伴侣特性以及随之而来的与年龄相关的聚集蛋白的积累。因此,α-晶体蛋白衍生的肽可能在衰老晶状体中白内障形成的发病机制中发挥作用。